Pharmadrug Inc
Pharmadrug Inc. operates as a specialty pharmaceutical company. The company focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. It also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs fo… Read more
Pharmadrug Inc (LMLLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.007x
Based on the latest financial reports, Pharmadrug Inc (LMLLF) has a cash flow conversion efficiency ratio of 0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-11.23K) by net assets ($-1.51 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharmadrug Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Pharmadrug Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pharmadrug Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmadrug Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Entheon Biomedical Corp
OTCQB:ENTBF
|
-0.265x |
|
HYUNGJI INNOVATION & CREATIVE Co.Ltd
KQ:011080
|
-0.071x |
|
SRIVARU Holding Limited
PINK:SVUHF
|
N/A |
|
OSHKOSH
BE:OK3
|
0.079x |
|
Tie Holding NV
F:TJH7
|
0.652x |
|
ALPHA MOS INH.EO 020
F:0MV
|
N/A |
|
d'Alba Global
KO:483650
|
0.000x |
|
Brigadier Gold Limited
PINK:BGADF
|
0.000x |
Annual Cash Flow Conversion Efficiency for Pharmadrug Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Pharmadrug Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.24 Million | $-756.62K | 0.608x | +32.65% |
| 2023-12-31 | $-1.47 Million | $-671.88K | 0.458x | +279.42% |
| 2022-12-31 | $8.84 Million | $-2.26 Million | -0.255x | -4.44% |
| 2021-12-31 | $16.87 Million | $-4.13 Million | -0.245x | -82.88% |
| 2020-12-31 | $10.57 Million | $-1.41 Million | -0.134x | +74.52% |
| 2019-12-31 | $4.46 Million | $-2.34 Million | -0.525x | -119.99% |
| 2018-12-31 | $-490.32K | $-1.29 Million | 2.625x | +259.96% |
| 2017-12-31 | $78.96K | $-129.60K | -1.641x | -61.05% |
| 2016-12-31 | $42.55K | $-43.36K | -1.019x | -3062.50% |
| 2015-12-31 | $7.79 Million | $-251.16K | -0.032x | +77.01% |
| 2014-12-31 | $7.93 Million | $-1.11 Million | -0.140x | +63.53% |
| 2013-12-31 | $641.25K | $-246.43K | -0.384x | -225.56% |
| 2012-12-31 | $1.15 Million | $-135.71K | -0.118x | -- |